KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Other Non Operating Income (2016 - 2025)

Evolent Health has reported Other Non Operating Income over the past 9 years, most recently at $252000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income changed N/A year-over-year to $252000.0; the TTM value through Dec 2025 reached $8000.0, changed N/A, while the annual FY2025 figure was $249000.0, N/A changed from the prior year.
  • Other Non Operating Income for Q4 2025 was $252000.0 at Evolent Health, up from -$196000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $10.2 million in Q4 2022 and troughed at -$21.3 million in Q4 2021.
  • A 4-year average of -$2.3 million and a median of -$44500.0 in 2021 define the central range for Other Non Operating Income.
  • On a YoY basis, Other Non Operating Income climbed as much as 1371.43% in 2022 and fell as far as 741.46% in 2022.
  • Year by year, Other Non Operating Income stood at -$21.3 million in 2021, then skyrocketed by 148.19% to $10.2 million in 2022, then crashed by 301.84% to -$20.7 million in 2023, then skyrocketed by 101.22% to $252000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for EVH at $252000.0 in Q4 2025, -$196000.0 in Q2 2025, and -$48000.0 in Q1 2025.